Evidence map›Paper›PMID 18475670›Full record

ArticleMediators of inflammation1995

Nitric oxide as a mediator of inflammation?-You had better believe it.

M J Miller, M B Grisham

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. The clinical and immunologic features of pulmonary fibrosis in sarcoidosis.Translational research : the journal of laboratory and clinical medicine · 2012
    Article
  4. Carvacrol attenuates mechanical hypernociception and inflammatory response.Naunyn-Schmiedeberg's archives of pharmacology · 2012
    Article
  5. Article
  6. Article
  7. Article
  8. Nitric oxide function in atherosclerosis.Mediators of inflammation · 1997
    Article
  9. Article
  10. Article
  11. Failure of L-NAME to cause inhibition of nitric oxide synthesis: role of inducible nitric oxide synthase.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 1996
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M J MillerDepartment of Pediatrics Louisiana State University Medical Center New Orleans LA USA.
M B Grisham
Louisiana State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide has enigmatic qualities in inflammation. In order to appreciate the precise contributions of nitric oxide to a pathophysiological process, one must account for enzyme source, coproduction of oxidants and antioxidant defences, time, rate of nitric oxide production, cellular source, peroxynitrite formation and effects on DNA (mutagenesis/apoptosis). We contend that there is ample evidence to consider nitric oxide as a molecular aggressor in inflammation, particularly chronic inflammation. Therapeutic benefit can be achieved by inhibition of inducible nitric oxide synthase and not the donation of additional nitric oxide. Furthermore, there is growing appreciation that nitric oxide and products derived thereof, are critical components linking the increased incidence of cancer in states of chronic inflammation.

Identifiers

PMID18475670
PMCPMC2365674
OpenAlexW2007414385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.